The TP53 Arg72Pro and MDM2 309G > T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

O.M. Sinilnikova, A.C. Antoniou, J. Simard, S. Healey, M. Leone, D. Sinnett, A.B. Spurdle, J. Beesley, X. Chen, M.H. Greene, J.T. Loud, F. Lejbkowicz, G. Rennert, S. Dishon, I.L. Andrulis, S.M. Domchek, K.L. Nathanson, S. Manoukian, P. Radice, I. KonstantopoulouI. Blanco, A.L. Laborde, M. Duran, A. Osorio, J. Benitez, U. Hamann, F.B.L. Hogervorst, T.A.M. van Os, J.J.P. Gille, S. Peock, M. Cook, C. Luccarini, D.G. Evans, F. Lalloo, R. Eeles, G. Pichert, R. Davidson, T. Cole, J. Cook, J. Paterson, C. Brewer, D.J. Hughes, I. Coupier, S. Giraud, F. Coulet, C. Colas, F. Soubrier, E. Rouleau, I. Bieche, R. Lidereau, L. Demange, C. Nogues, H.T. Lynch, R.K. Schmutzler, B. Versmold, C. Engel, A. Meindl, N. Arnold, C. Sutter, H. Deissler, D. Schaefer, U.G. Froster, K. Aittomaki, H. Nevanlinna, L. McGuffog, D.F. Easton, G. Chenevix-Trench, D. Stoppa-Lyonnet

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1456-1460
JournalBritish journal of cancer
Issue number8
Publication statusPublished - 2009

Cite this